Found: 8
Select item for more details and to access through your institution.
First‐in‐Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E6742, a Dual Antagonist of Toll‐like Receptors 7 and 8, in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 4, p. 363, doi. 10.1002/cpdd.1176
- By:
- Publication type:
- Article
PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY, AND TOLERABILITY OF LY3202626, A NOVEL BACE1 INHIBITOR, IN HEALTHY SUBJECTS AND PATIENTS WITH ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P418, doi. 10.1016/j.jalz.2016.06.791
- By:
- Publication type:
- Article
BACE inhibitor LY2886721 safety and central and peripheral PK and PD in healthy subjects (HSs)
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Safety, pharmacokinetics and quantitative EEG modulation of TAK‐071, a novel muscarinic M1 receptor positive allosteric modulator, in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 2, p. 600, doi. 10.1111/bcp.14975
- By:
- Publication type:
- Article
Safety and pharmacokinetic profiles of MGS0274 besylate (TS‐134), a novel metabotropic glutamate 2/3 receptor agonist prodrug, in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 11, p. 2286, doi. 10.1111/bcp.14331
- By:
- Publication type:
- Article
The effect of LCZ696 (sacubitril/valsartan) on amyloid-β concentrations in cerebrospinal fluid in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 81, n. 5, p. 878, doi. 10.1111/bcp.12861
- By:
- Publication type:
- Article
A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor.
- Published in:
- Psychopharmacology, 2016, v. 233, n. 21/22, p. 3787, doi. 10.1007/s00213-016-4412-9
- By:
- Publication type:
- Article
Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy Volunteers.
- Published in:
- 2019
- By:
- Publication type:
- journal article